YuanMing Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

YuanMing Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2020	CF PharmTech	$51.0M Series F	—	BioTrack Capital, CICC Qichen, CICC Qide, GP M&A Fund, Passion Capital, Watson Investment
Jul 5, 2018	Adlai Nortye	$53.0M Series B	—	Matrix Partners China, Yahui Investment
May 14, 2018	Ansun BioPharma	$85.0M Series A	Lilly Asia Ventures, Sinopharm Capital	3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, Oceanpine Capital, VI Ventures
Mar 8, 2018	JW Therapeutics	$90.0M Series A	Hongshan Capital Group (Sequoia Capital China), Temasek, YuanMing Capital	AVICT Global, Juno Therapeutics, WuXi AppTec, Yipu Capital
May 1, 2017	CANbridge Pharmaceuticals	$25.0M Series B	Lapam Capital	Qiming Venture Partners, Biossom Investment Management, Haoyue Capital, WuXi AppTec, Yanyuan Capital
Jan 9, 2017	Ascentage Pharma	$72.1M Series B	Future Industry Ventures	Efung Capital, Hidragon Capital, KIP Capital, Oriza Ventures, Shiyu Capital
Aug 15, 2015	Ascentage Pharma	$15.5M Series A	Oriza Ventures, YuanMing Capital	BioVentures Investors, Efung Capital, Grains Valley Venture Capital